Midland Wealth Advisors LLC Has $778,000 Stake in MetLife, Inc. (NYSE:MET)

Midland Wealth Advisors LLC lowered its stake in shares of MetLife, Inc. (NYSE:MET) by 8.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 9,505 shares of the financial services provider’s stock after selling 848 shares during the period. Midland Wealth Advisors LLC’s holdings in MetLife were worth $778,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. United Asset Strategies Inc. raised its stake in shares of MetLife by 1.1% in the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock valued at $895,000 after purchasing an additional 120 shares during the period. Barrett & Company Inc. boosted its position in shares of MetLife by 1.0% during the fourth quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock worth $978,000 after buying an additional 121 shares during the period. Great Valley Advisor Group Inc. grew its holdings in shares of MetLife by 1.3% during the third quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock worth $781,000 after buying an additional 123 shares in the last quarter. J.W. Cole Advisors Inc. raised its position in MetLife by 2.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock valued at $495,000 after buying an additional 126 shares during the last quarter. Finally, Avestar Capital LLC lifted its stake in MetLife by 3.2% in the 3rd quarter. Avestar Capital LLC now owns 4,264 shares of the financial services provider’s stock valued at $352,000 after acquiring an additional 133 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Trading Up 0.1 %

MET stock opened at $82.28 on Monday. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The stock has a market cap of $56.05 billion, a price-to-earnings ratio of 13.78, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. The company has a fifty day moving average price of $83.72 and a two-hundred day moving average price of $82.35. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Equities analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.65%. MetLife’s payout ratio is currently 36.52%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on MET. BMO Capital Markets began coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective on the stock. Keefe, Bruyette & Woods lowered their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Wells Fargo & Company boosted their price target on shares of MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Barclays lowered their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Finally, JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.